Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Net Cash Flow (2020 - 2023)

Historic Net Cash Flow for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $41.8 million.

  • Terns Pharmaceuticals' Net Cash Flow fell 4791.62% to $41.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$63.4 million, marking a year-over-year decrease of 16626.62%. This contributed to the annual value of $81.6 million for FY2024, which is 22860.5% up from last year.
  • Terns Pharmaceuticals' Net Cash Flow amounted to $41.8 million in Q4 2023, which was down 4791.62% from -$43.0 million recorded in Q3 2023.
  • In the past 5 years, Terns Pharmaceuticals' Net Cash Flow registered a high of $80.2 million during Q4 2022, and its lowest value of -$103.3 million during Q2 2023.
  • Its 4-year average for Net Cash Flow is $4.2 million, with a median of -$1.7 million in 2020.
  • Data for Terns Pharmaceuticals' Net Cash Flow shows a peak YoY increase of 518181.82% (in 2021) and a maximum YoY decrease of 49299.55% (in 2021) over the last 5 years.
  • Terns Pharmaceuticals' Net Cash Flow (Quarter) stood at $61.2 million in 2020, then plummeted by 127.9% to -$17.1 million in 2021, then soared by 569.8% to $80.2 million in 2022, then crashed by 47.92% to $41.8 million in 2023.
  • Its Net Cash Flow stands at $41.8 million for Q4 2023, versus -$43.0 million for Q3 2023 and -$103.3 million for Q2 2023.